Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1766782

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1766782

United States Hormonal Disorders Market Outlook to 2033 - Thyroid Function Tests

PUBLISHED:
PAGES: 34 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4995
PDF (Site License)
USD 9990
PDF (Global License)
USD 14985

Add to Cart

GlobalData's "United States Hormonal Disorders Market Outlook to 2033" is a comprehensive databook report, covering key market data on the United States Hormonal Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Thyroid Function Tests

The United States Hormonal Disorders Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Hormonal Disorders Market.
  • Global corporate-level profiles of key companies operating within the United States Hormonal Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Hormonal Disorders is segmented as follows -

  • Thyroid Function Tests

Reasons to Buy

The United States Hormonal Disorders Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Product Code: GDME25570CCDB

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Hormonal Disorders Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Hormonal Disorders Market, United States

  • 3.1 Hormonal Disorders Market, United States, Revenue ($m), 2018-2033
    • 3.1.1 Thyroid Function Tests Market, United States, Revenue ($m), by Segment, 2018-2033
  • 3.2 Hormonal Disorders Market, United States, Volume (Units), 2018-2033
    • 3.2.1 Thyroid Function Tests Market, United States, Volume (Units), by Segment, 2018-2033
  • 3.3 Hormonal Disorders Market, United States, Average Price ($), 2018-2033
  • 3.4 Hormonal Disorders Market, United States, Company Share by Revenue ($m), 2024

4 Overview of Key Companies in United States, Hormonal Disorders Market

  • 4.1 Siemens Healthineers AG
    • 4.1.1 Company Overview
  • 4.2 Beckman Coulter Inc
    • 4.2.1 Company Overview
  • 4.3 Roche Diagnostics International Ltd
    • 4.3.1 Company Overview
  • 4.4 Abbott Laboratories
    • 4.4.1 Company Overview
  • 4.5 Ortho Clinical Diagnostics Holdings Plc
    • 4.5.1 Company Overview
  • 4.6 Inova Diagnostics Inc
    • 4.6.1 Company Overview

5 Hormonal Disorders Market Pipeline Products

6 Financial Deals Landscape

  • 6.1 Acquisition
    • 6.1.1 Searle Denies Rumour to Acquire 51% Stake in Abbott Laboratories
    • 6.1.2 VION Biosciences Acquires Ansh Labs
  • 6.2 Equity Offerings
    • 6.2.1 Endogenex Raises USD69.56 Million in Equity Financing
  • 6.3 Venture Financing
    • 6.3.1 Endogenex Raises USD88 Million in Series C Financing

7 Recent Developments

  • 7.1 Financial Announcements
    • 7.1.1 Jun 27, 2024: Abbott Hosts Conference Call for Second-Quarter Earnings
  • 7.2 Product News
    • 7.2.1 Oct 21, 2024: Inception Fertility Announces the Acceptance of 36 Abstracts to be Presented at the 2024 ASRM Scientific Congress

8 Appendix

  • 8.1 Research Methodology
    • 8.1.1 Coverage
    • 8.1.2 Secondary Research
    • 8.1.3 Primary Research
    • 8.1.4 Market Modeling and Forecasting
    • 8.1.5 Company Share Analysis
    • 8.1.6 Benchmarking
  • 8.2 GlobalData Consulting
  • 8.3 Contact Us
  • 8.4 Disclaimer
Product Code: GDME25570CCDB

List of Table

List of Tables

  • Table 1: Hormonal Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 2: Thyroid Function Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 3: Hormonal Disorders Market, United States, Volume (Units), 2018-2033
  • Table 4: Thyroid Function Tests Market, United States, Volume (Units), 2018-2033
  • Table 5: Hormonal Disorders Market, United States, Average Price ($), 2018-2033
  • Table 6: Hormonal Disorders Market, United States, Company Share by Revenue ($m), 2024
  • Table 7: Hormonal Disorders Market Pipeline Products
  • Table 8: Searle Denies Rumour to Acquire 51% Stake in Abbott Laboratories
  • Table 9: VION Biosciences Acquires Ansh Labs
  • Table 10: Endogenex Raises USD69.56 Million in Equity Financing
  • Table 11: Endogenex Raises USD88 Million in Series C Financing
  • Table 12: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

List of Figure

List of Figures

  • Figure 1: Hormonal Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 2: Thyroid Function Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 3: Hormonal Disorders Market, United States, Volume (Units), 2018-2033
  • Figure 4: Thyroid Function Tests Market, United States, Volume (Units), 2018-2033
  • Figure 5: Hormonal Disorders Market, United States, Company Share (%), 2024
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!